Please Wait.....
Report
India Precision Medicine Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 250 Pages I EMR Inc.
The India precision medicine market was valued at USD 2.40 Billion in 2024, driven by increasing adoption of genomics-based diagnostics and rising government support for personalized healthcare initiatives across the region. The market is anticipated to grow at a CAGR of 11.80% during the forecast period of 2025-2034, with the values likely to reach USD 7.32 Billion by 2034. The market benefits from expanding healthcare infrastructure and growing demand for targeted therapies. Advancements in AI-driven analytics and the integration of electronic health records are expected to boost adoption in the forecast period, contributing to improved patient outcomes and enhanced treatment efficacy.
India Precision Medicine Market Overview
Precision medicine is an advanced medical approach that tailors treatment and prevention strategies to individual genetic, environmental, and lifestyle factors. It aims to improve patient outcomes by providing more accurate diagnoses and targeted therapies based on personal variability. The precision medicine market in India is experiencing significant growth due to increasing healthcare digitization, rising chronic disease prevalence, and advancements in genomics and data analytics. Government initiatives and growing investments in biotechnology further support market expansion. The market is poised to grow at a CAGR of 11.80% during the forecast period of 2025-2034, driven by evolving clinical practices and the adoption of personalized healthcare solutions.
India Precision Medicine Market Growth Drivers
Increasing Prevalence of Cancer to Elevate the Market Growth
The rising prevalence of cancer is emerging as a highly significant growth driver in the precision medicine market in India. According to the Indian Council of Medical Research (ICMR), it was estimated that over 1.4 million new cancer cases were diagnosed across India in 2023 alone. This rising cancer burden is driving strong demand for personalized and targeted therapies that enhance treatment efficacy and reduce adverse effects. As a result, the adoption of precision medicine is accelerating across the country, thereby fueling substantial and continuous expansion of the market.
India Precision Medicine Market Trends
Key trends in the market include the increasing adoption of gene therapy and the formation of strategic genomic collaborations.
Rising Adoption of Gene Therapy to Fuel Innovation in the Market
The growing shift toward gene-based, personalized treatment is redefining the precision medicine landscape in India. Reflecting this trend, in February 2025, India's Union Minister inaugurated the Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu. The facility, leveraging genomic data and AI, aims to deliver individualized therapies. This advancement is set to accelerate the growth and accessibility of precision medicine across India.
Strategic Collaborations Set to Boost India Precision Medicine Market Value
The market is witnessing a trend towards the expansion of genomic diagnostics through strategic partnerships. In April 2025, Vgenomics and Meril Genomics announced a collaboration to enhance access to advanced genomic tools across Indian hospitals and research institutions. This initiative includes non-invasive prenatal testing, targeted sequencing for tuberculosis, and Whole Exome Sequencing for rare diseases. Such developments are expected to significantly accelerate market growth and patient care innovation.
India Precision Medicine Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Diagnostics
??- Genetic Tests
??- Direct to Consumer Tests
??- Esoteric Tests
??- Others
- Therapeutics
??- Medical Devices
??- Drugs Monoclonal Antibodies Inhibitor Drugs Cell & Gene Therapies Antiviral & Anti-Retroviral Drugs Others
- Others
Market Breakup by Application
- Oncology
- Neurology
- Immunology
- Hematology
- Respiratory
- Others
Market Breakup by End User
- Hospitals and Clinics
- Clinical Laboratories
- Research and Academic Institutes
- Homecare Settings
- Others
Market Breakup by Region
- North India
- East and Central India
- West India
- South India
India Precision Medicine Market Share
Segmentation Based on Application to Witness Substantial Growth
Precision medicines have a wide range of applications across various medical fields, including oncology, neurology, immunology, hematology, respiratory diseases, and others. According to the Indian Council of Medical Research (ICMR), India recorded over 14 lakh new cancer cases in 2023, underscoring the urgent need for targeted treatments. This significant cancer burden positions oncology as the leading application segment within the precision medicine market. The increasing adoption of personalized therapies, driven by advances in genetic testing and molecular diagnostics, further supports oncology's dominance. Although other segments, such as neurology and immunology, are growing steadily, oncology is expected to remain the primary driver of market growth in India.
India Precision Medicine Market Analysis by Region
The precision medicine market report in India covers North India, East and Central India, West India, and South India. Among these, South India is expected to lead due to its robust healthcare infrastructure and progressive medical initiatives. For instance, in April 2025, SunAct Cancer Institute and Smita Memorial Hospital launched a CAR T-Cell Therapy Centre in Kerala, emphasizing precision oncology, pediatric care, and international clinical trials. This development underscores South India's growing role in advancing affordable, cutting-edge cell and gene therapies.
Leading Players in the India Precision Medicine Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Strand Life Sciences
Strand Life Sciences, established in 2000 and headquartered in Bangalore, India, is a life sciences technology company specializing in bioinformatics, diagnostics, and clinical research. In April 2024, it entered a strategic partnership with SOPHiA GENETICS to advance precision medicine. The collaboration aimed to integrate Strand's bioinformatics platforms and curated variant databases with the SOPHiA DDM Platform to enhance genomic analysis and support data-driven healthcare decisions, particularly benefiting patient outcomes in India.
MapmyGenome
Established in 2012 and headquartered in Hyderabad, MapmyGenome India Ltd., is a key player in the India precision medicine market. The company specializes in personal genomics and preventive health solutions. Its product, Cardiomap, exemplifies its focus on cardiovascular health by assessing genetic predisposition to heart conditions. MapmyGenome integrates genetic insights with lifestyle data to support personalized prevention strategies, advancing precision medicine in India.
Redcliffe Labs
Redcliffe Labs is actively contributing to the India precision medicine market through innovative diagnostic solutions. It was established in 2018 and is headquartered in Noida, India. In May 2025, the company launched Femcliffe, India's first women-centric diagnostic platform. Femcliffe offers tailored diagnostic packages across all stages of a woman's life, addressing conditions like PCOS, reproductive disorders, and metabolic diseases, with services available nationwide.
Novartis AG
Headquartered in Basel, Switzerland, and founded in 1996, Novartis AG is actively engaged in the precision medicine market. The company offers extensive educational and digital resources aimed at enhancing biomarker testing and personalized therapies, particularly in oncology and hematology. Through initiatives such as molecular diagnostics in personalized cancer care and essential elements of biomarker testing, Novartis supports healthcare professionals in delivering targeted, individualized treatments aligned with precision medicine principles.
Other key players in the market include MedGenome Labs, CORE Diagnostics, Positive Bioscience, Neuberg Diagnostics, Leucine Rich Bio, Sarepta Therapeutics, Inc., and GSK plc.
Key Questions Answered in the India Precision Medicine Market Report
- What was the India precision medicine market value in 2024?
- What is the India precision medicine market forecast outlook for 2025-2034?
- What are the major factors aiding the India precision medicine market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major India precision medicine market trends?
- Which type is expected to dominate the market segment?
- Which application is projected to lead the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players involved in the India precision medicine market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Precision Medicine Market Overview
3.1 Asia Pacific Precision Medicine Market
3.1.1 Asia Pacific Precision Medicine Market Historical Value (2018-2024)
3.1.2 Asia Pacific Precision Medicine Market Forecast Value (2025-2034)
3.2 India Precision Medicine Market
3.2.1 India Precision Medicine Market Historical Value (2018-2024)
3.2.2 India Precision Medicine Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 India Precision Medicine Market Landscape
5.1 India Precision Medicine Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 India Precision Medicine Market: Product Landscape
5.2.1 Analysis by Type
5.2.2 Analysis by Application
6 India Precision Medicine Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 India Precision Medicine Market Segmentation (218-2034)
7.1 India Precision Medicine Market (2018-2034) by Type
7.1.1 Market Overview
7.1.2 Diagnostics
7.1.2.1 Genetic Tests
7.1.2.2 Direct to Consumer Tests
7.1.2.3 Esoteric Tests
7.1.2.4 Othersx
7.1.3 Therapeutics
7.1.3.1 Medical Devices
7.1.3.2 Drugs
7.1.3.2.1 Monoclonal Antibodies
7.1.3.2.2 Inhibitor Drugs
7.1.3.2.3 Cell & Gene Therapies
7.1.3.2.4 Antiviral & Anti-Retroviral Drugs
7.1.3.2.5 Others
7.1.4 Others
7.2 India Precision Medicine Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Oncology
7.2.3 Neurology
7.2.4 Immunology
7.2.5 Hematology
7.2.6 Respiratory
7.2.7 Others
7.3 India Precision Medicine Market (2018-2034) by End User
7.3.1 Market Overview
7.3.2 Hospitals and Clinics
7.3.3 Clinical Laboratories
7.3.4 Research and Academic Institutes
7.3.5 Homecare Settings
7.3.6 Others
7.4 India Precision Medicine Market (2018-2034) by Region
7.4.1 Market Overview
7.4.2 North India
7.4.3 East and Central India
7.4.4 West India
7.4.5 South India
8 Regulatory Framework
9 Patent Analysis
9.1 Analysis by Type of Patent
9.2 Analysis by Publication Year
9.3 Analysis by Patent Age
9.4 Analysis by CPC Analysis
9.5 Analysis by Patent Valuation
10 Funding and Investment Analysis
10.1 Analysis by Funding Instances
10.2 Analysis by Type of Funding
10.3 Analysis by Funding Amount
10.4 Analysis by Leading Players
10.5 Analysis by Leading Investors
10.6 Analysis by Geography
11 Strategic Initiatives
11.1 Analysis by Partnership Instances
11.2 Analysis by Type of Initiatives
11.3 Analysis by Leading Players
11.4 Analysis by Geography
12 Supplier Landscape
12.1 Market Share Analysis, By Region
12.2 MedGenome Labs
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Company News and Developments
12.2.5 Certifications
12.3 Strand Life Sciences
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Company News and Developments
12.3.5 Certifications
12.4 MapmyGenome
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Company News and Developments
12.4.5 Certifications
12.5 CORE Diagnostics
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Company News and Developments
12.5.5 Certifications
12.6 Positive Bioscience
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Company News and Developments
12.6.5 Certifications
12.7 Neuberg Diagnostics
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Company News and Developments
12.7.5 Certifications
12.8 Leucine Rich Bio
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Company News and Developments
12.8.5 Certifications
12.9 Redcliffe Labs
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Company News and Developments
12.9.5 Certifications
12.10 Novartis AG
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Company News and Developments
12.10.5 Certifications
12.11 GSK plc
12.11.1 Financial Analysis
12.11.2 Product Portfolio
12.11.3 Demographic Reach and Achievements
12.11.4 Company News and Developments
12.11.5 Certifications
12.12 Sarepta Therapeutics, Inc.
12.12.1 Financial Analysis
12.12.2 Product Portfolio
12.12.3 Demographic Reach and Achievements
12.12.4 Company News and Developments
12.12.5 Certifications
13 India Precision Medicine Market - Distribution Model (Additional Insight)
13.1 Overview
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security